(E)-TAMOXIFEN,
cis-Tamoxifen,
Tamoxifen (E),
UNII-56SY0DIL6N,
13002-65-8,
{2-[4-(1,2-diphenylbut-1-en-1-yl)phenoxy]ethyl}dimethylamine,
BRN 2062021,
56SY0DIL6N,
Ethanamine, 2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, (E)-,
Ethylamine, N,N-dimethyl-2-(p-(1,2-diphenyl-1-butenyl)phenoxy)-, (E)-,
C26H29NO,
Novadex,
(2-[4-(1,2-Diphenylbut-1-en-1-yl)phenoxy]ethyl)dimethylamine,
Nolgen (Salt/Mix),
Noltam (Salt/Mix),
Tamoxifen, (E)-,
TMX (Salt/Mix),
AC1MHUCW,
Apo-Tamox (Salt/Mix),
SCHEMBL4085,
Tamoxifen citrate (Salt/Mix),
CHEMBL300460,
SCHEMBL1056785,
Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]-N,N-dimethyl-,
UPCMLD-DP027:001,
CHEBI:92766,
NKANXQFJJICGDU-OCEACIFDSA-N,
7728-73-6,
ZINC1530690,
AKOS015895172,
FS-3812,
NE46547,
NCGC00161604-01,
CPD001491671,
LS-68100,
SAM002703133,
I06-0294,
J-005739,
BRD-K43744935-048-01-6,
(Z)-2-(p-(1,2-Diphenyl-1-butenyl)-phenoxy)-N,N-dimethylethylamine,
(Z)-2-[p-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine,
2-[4-[(E)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine,
cis-N,N-Dimethyl-2-(p-(1,2-diphenyl-1-butenyl)phenoxy)ethylamine,
(2-{4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenoxy}ethyl)dimethylamine,
2-[4-[(E)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethyl-ethanamine,
cis-1-(p-(2-(N,N-Dimethylamino)ethoxy)phenyl)-1,2-diphenylbut-1-ene,
N-(2-(4-[(1E)-1,2-Diphenyl-1-butenyl]phenoxy)ethyl)-N,N-dimethylamine #,
tamoxifen,
Nolvadex,
Tamoxifen citrate,
Tamoxifen Citrate E-isomer,
C26-H29-N-O,
CID3032583,
ICI 46,474,
10540-29-1,
[Z]-1-[p-Dimethylaminoethoxyphenyl]-1,2-diphenyl-1-butene,
Ethanamine, 2-[4-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethyl-, (Z)-,
Ethanamine, 2-[4-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethyl-,(E)-,
Ethylamine, 2-[p-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethyl-,(E)-,
Ethylamine, N,N-dimethyl-2-(p-(1,2-diphenyl-1-butenyl)phenoxy)-, (Z)-,
54965-24-1,